Skip to main content
An official website of the United States government
Email

Head and Neck SPOREs

SPOREs in head and neck cancer support translational research on cancers of the upper aero-digestive tract. In 2024, an estimated 58,450 people in the United States were diagnosed with oral cavity and oropharyngeal cancer and 12,230 individuals died of the disease. For laryngeal cancer, an estimated 12,650 people were diagnosed that year and there were 3,880 people who succumbed to the disease.

Known risk factors for head & neck cancer include smoking, alcohol use, and human papillomavirus (HPV) infection. The first SPOREs in head and neck cancer were established in 2002, and co-funding for this program is received by the National Institute of Dental and Craniofacial Research.

University of Colorado Cancer Center Head and Neck Cancer SPORE

University of Pittsburgh Head and Neck Cancer SPORE

University of Wisconsin Head and Neck Cancer SPORE

Yale University Head and Neck Cancer SPORE

 

  • Reviewed:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Head and Neck SPOREs was originally published by the National Cancer Institute.”

Email